Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ruzicka

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Oncology|September 26, 2022
Lymphoma tumor burden before chimeric antigen receptor T-Cell treatment: RECIL vs. Lugano vs. metabolic tumor assessmentMichael Winkelmann, Veit L Bücklein, Viktoria Blumenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 13, 2022
Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapyMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 2, 2024
Effects of cognitive training and group psychotherapy on cognitive performance of post COVID-19 patients: an exploratory and non-randomized clinical trialTarek Jebrini, Anabel Thomas, Simone Sachenbacher, et al.
Infection|January 17, 2025
Predicting work ability impairment in post COVID-19 patients: a machine learning model based on clinical parametersTarek Jebrini, Michael Ruzicka, Felix Völk, et al.
Leukemia|November 20, 2019
RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockadeMichael Ruzicka, Lars M Koenig, Simone Formisano, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 13, 2023
Substantial differences in perception of disease severity between post COVID-19 patients, internists, and psychiatrists or psychologists: the Health Perception Gap and its clinical implicationsMichael Ruzicka, Gerardo Jesus Ibarra Fonseca, Simone Sachenbacher, et al.
Infection|February 7, 2024
Persistent immune abnormalities discriminate post-COVID syndrome from convalescenceJulia Sbierski-Kind, Stephan Schlickeiser, Svenja Feldmann, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 13, 2024
Characterization of cognitive symptoms in post COVID-19 patientsMichael Ruzicka, Simone Sachenbacher, Fides Heimkes, et al.
Intensive Care Medicine|June 30, 2026
The HLH-Risk-Calculator is a machine learning-based tool to predict course & mortality of secondary hemophagocytic lymphohistiocytosisMichael Ruzicka, Hans Christian Stubbe, Josia Fauser, et al.
Infection|July 11, 2023
Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)Fridolin Steinbeis, Charlotte Thibeault, Sarah Steinbrecher, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Oncology|September 26, 2022
Lymphoma tumor burden before chimeric antigen receptor T-Cell treatment: RECIL vs. Lugano vs. metabolic tumor assessmentMichael Winkelmann, Veit L Bücklein, Viktoria Blumenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 13, 2022
Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapyMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 2, 2024
Effects of cognitive training and group psychotherapy on cognitive performance of post COVID-19 patients: an exploratory and non-randomized clinical trialTarek Jebrini, Anabel Thomas, Simone Sachenbacher, et al.
Infection|January 17, 2025
Predicting work ability impairment in post COVID-19 patients: a machine learning model based on clinical parametersTarek Jebrini, Michael Ruzicka, Felix Völk, et al.
Leukemia|November 20, 2019
RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockadeMichael Ruzicka, Lars M Koenig, Simone Formisano, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 13, 2023
Substantial differences in perception of disease severity between post COVID-19 patients, internists, and psychiatrists or psychologists: the Health Perception Gap and its clinical implicationsMichael Ruzicka, Gerardo Jesus Ibarra Fonseca, Simone Sachenbacher, et al.
Infection|February 7, 2024
Persistent immune abnormalities discriminate post-COVID syndrome from convalescenceJulia Sbierski-Kind, Stephan Schlickeiser, Svenja Feldmann, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 13, 2024
Characterization of cognitive symptoms in post COVID-19 patientsMichael Ruzicka, Simone Sachenbacher, Fides Heimkes, et al.
Intensive Care Medicine|June 30, 2026
The HLH-Risk-Calculator is a machine learning-based tool to predict course & mortality of secondary hemophagocytic lymphohistiocytosisMichael Ruzicka, Hans Christian Stubbe, Josia Fauser, et al.
Infection|July 11, 2023
Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)Fridolin Steinbeis, Charlotte Thibeault, Sarah Steinbrecher, et al.
Pageof 2